Elias Gebru

504 total citations
19 papers, 409 citations indexed

About

Elias Gebru is a scholar working on Pharmacology, Molecular Medicine and Oncology. According to data from OpenAlex, Elias Gebru has authored 19 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Molecular Medicine and 4 papers in Oncology. Recurrent topics in Elias Gebru's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Microbial infections and disease research (4 papers). Elias Gebru is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Microbial infections and disease research (4 papers). Elias Gebru collaborates with scholars based in South Korea, United States and China. Elias Gebru's co-authors include Seung‐Chun Park, Henrique Cheng, Zhiqiang Chang, Dereje Damte, Joong‐Su Lee, Myeongjin Choi, Seung‐Jin Lee, Jong-Choon Kim, Man Hee Rhee and Sung-Jae Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Elias Gebru

19 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elias Gebru South Korea 12 129 92 87 80 67 19 409
Dereje Damte South Korea 14 131 1.0× 95 1.0× 108 1.2× 56 0.7× 65 1.0× 24 425
S. Carli Italy 13 149 1.2× 92 1.0× 78 0.9× 50 0.6× 105 1.6× 38 550
Chandra Datta Sumi Australia 6 170 1.3× 90 1.0× 194 2.2× 86 1.1× 141 2.1× 13 654
S. De Boever Belgium 12 140 1.1× 36 0.4× 91 1.0× 33 0.4× 71 1.1× 15 490
Ákos Jerzsele Hungary 15 68 0.5× 146 1.6× 151 1.7× 62 0.8× 143 2.1× 88 687
Joong‐Su Lee South Korea 11 64 0.5× 45 0.5× 109 1.3× 31 0.4× 80 1.2× 17 344
G Semjén Hungary 12 87 0.7× 50 0.5× 70 0.8× 69 0.9× 49 0.7× 37 397
Jorge Oscar Errecalde Argentina 14 126 1.0× 31 0.3× 67 0.8× 34 0.4× 39 0.6× 49 431
Nikolina Rusenova Bulgaria 9 105 0.8× 27 0.3× 37 0.4× 80 1.0× 75 1.1× 46 333

Countries citing papers authored by Elias Gebru

Since Specialization
Citations

This map shows the geographic impact of Elias Gebru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Gebru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Gebru more than expected).

Fields of papers citing papers by Elias Gebru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Gebru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Gebru. The network helps show where Elias Gebru may publish in the future.

Co-authorship network of co-authors of Elias Gebru

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Gebru. A scholar is included among the top collaborators of Elias Gebru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Gebru. Elias Gebru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gebru, Elias, et al.. (2022). Bipolar Disorder after COVID-19 Infection: A Case Report from an Ethiopian Perspective. SHILAP Revista de lepidopterología. 2022. 1–5. 2 indexed citations
2.
Gebru, Elias, Zhiqiang Chang, Henrique Cheng, et al.. (2014). Comparative Pharmacokinetics of Orbifloxacin Following a Single Intravenous or Oral Administration to Healthy and Diabetic Rats. Ajakirjad. Journals by UT. 38(2). 99–107. 2 indexed citations
3.
Gebru, Elias, et al.. (2012). The <i>In Vitro</i> Activity of 15 Antimicrobial Agents against Bacterial Isolates from Dogs. Journal of Veterinary Medical Science. 74(8). 1091–1094. 15 indexed citations
4.
Lee, Seung‐Jin, et al.. (2011). The in vitro antibacterial activity of florfenicol in combination with amoxicillin or cefuroxime against pathogenic bacteria of animal origin.. Pakistan Veterinary Journal. 31(2). 141–144. 10 indexed citations
5.
Gebru, Elias, Myeongjin Choi, Seung‐Jin Lee, Dereje Damte, & Seung‐Chun Park. (2011). Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin. Journal of Medical Microbiology. 60(10). 1512–1522. 39 indexed citations
6.
7.
Damte, Dereje, et al.. (2011). Inflammatory responses toMycoplasma hyopneumoniaein murine alveolar macrophage cell lines. New Zealand Veterinary Journal. 59(4). 185–190. 25 indexed citations
8.
Gebru, Elias, Dereje Damte, Joong‐Su Lee, et al.. (2011). The role of Janus kinase 2 (JAK2) activation in pneumococcal EstA protein-induced inflammatory response in RAW 264.7 macrophages. Microbial Pathogenesis. 51(4). 297–303. 6 indexed citations
9.
Chang, Zhiqiang, Elias Gebru, Sam‐Pin Lee, et al.. (2011). In Vitro Antioxidant and Anti-Inflammatory Activities of Protocatechualdehyde Isolated from Phellinus gilvus. Journal of Nutritional Science and Vitaminology. 57(1). 118–122. 58 indexed citations
10.
Gebru, Elias, Seung‐Jin Lee, Jong-Choon Kim, & Seung‐Chun Park. (2011). Allometric Scaling of Orbifloxacin Disposition in Nine Mammal Species: A Retrospective Analysis. Journal of Veterinary Medical Science. 73(6). 817–820. 4 indexed citations
11.
Hwang, Mihyun, Dereje Damte, Joong‐Su Lee, et al.. (2010). Mycoplasma hyopneumoniae induces pro-inflammatory cytokine and nitric oxide production through NFκB and MAPK pathways in RAW264.7 cells. Veterinary Research Communications. 35(1). 21–34. 30 indexed citations
12.
13.
Kim, Eun Young, Elias Gebru, Joong‐Su Lee, Jong-Choon Kim, & Seung‐Chun Park. (2010). Pharmacokinetics of a Florfenicol-Tylosin Combination after Intravenous and Intramuscular Administration to Beagle Dogs. Journal of Veterinary Medical Science. 73(4). 463–466. 13 indexed citations
14.
Chang, Zhiqiang, Joong‐Su Lee, Elias Gebru, et al.. (2010). Immunomodulatory activities and subacute toxicity of a novel β-glucan fromPaenibacillus polymyxaJB115 in rats. Immunopharmacology and Immunotoxicology. 33(1). 124–134. 4 indexed citations
15.
Kang, Eun Hee, Elias Gebru, Myung Hee Kim, Henrique Cheng, & Seung‐Chun Park. (2009). EstA protein, a novel virulence factor of Streptococcus pneumoniae, induces nitric oxide and pro-inflammatory cytokine production in RAW 264.7 macrophages through NF-κB/MAPK. Microbial Pathogenesis. 47(4). 196–201. 25 indexed citations
16.
Chang, Zhiqiang, Joong‐Su Lee, Elias Gebru, et al.. (2009). Mechanism of macrophage activation induced by β-glucan produced from Paenibacillus polymyxa JB115. Biochemical and Biophysical Research Communications. 391(3). 1358–1362. 30 indexed citations
17.
Gebru, Elias, Joong‐Su Lee, Zhiqiang Chang, et al.. (2009). Integration of Pharmacokinetic and Pharmacodynamic Indices of Orbifloxacin in Beagle Dogs after a Single Intravenous and Intramuscular Administration. Antimicrobial Agents and Chemotherapy. 53(7). 3024–3029. 17 indexed citations
18.
Hwang, Mihyun, et al.. (2008). Killing rate curve and combination effects of surfactin C produced from Bacillus subtilis complex BC1212 against pathogenic Mycoplasma hyopneumoniae. World Journal of Microbiology and Biotechnology. 24(10). 2277–2282. 6 indexed citations
19.
Kim, Mihee, Elias Gebru, Zhiqiang Chang, et al.. (2008). Comparative Pharmacokinetics of Tylosin or Florfenicol after a Single Intramuscular Administration at Two Different Doses of Tylosin-Florfenicol Combination in Pigs. Journal of Veterinary Medical Science. 70(1). 99–102. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dereje Damte Breakdown of academic impact, for papers by S. Carli Breakdown of academic impact, for papers by Chandra Datta Sumi Breakdown of academic impact, for papers by S. De Boever Breakdown of academic impact, for papers by Ákos Jerzsele Breakdown of academic impact, for papers by Joong‐Su Lee Breakdown of academic impact, for papers by G Semjén Breakdown of academic impact, for papers by Jorge Oscar Errecalde Breakdown of academic impact, for papers by Nikolina Rusenova
Rankless by CCL
2026